Atomwise is one of the companies leading the charge in AI-powered drug discovery

Borne out of academic research, Atomwise now has over $50 million in funding and partnerships with major players in the pharmaceutical industry.

Source: bizjournals.com Health Care:Biotechnology headlines - January 17, 2019 Category: Biotechnology Authors: Richard Procter Source Type: news